Small and heterogeneous group of patients mostly composed of facial tumours with irradiation involving the hypothalamic-pituitary area Those who have received irradiation on the hypothalamic-pituitary area generally have growth hormone deficiency; the mechanism for growth retardation is less clear in some of the other cases Haematological malignancies, HM Mostly leukaemias and lymphomas; also includes bone marrow transplantation for leukaemia Growth hormone deficiency after prophylactic craniospinal irradiation or total body irradiation; in addition, growth can be altered by other mechanisms (direct radiation-induced damage to the spine; toxic effect of chemotherapy to the growth plate) Small for gestational age defined as birth weight and/or birth length <2SDS, based on country-specific reference data.
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Because the initial diagnosis for which patients receive r-hGH heavily influences their future mortality and other outcomes, and there were many different initial diagnoses, often with few cases per diagnosis, we devised eleven categories of initial diagnosis (Table A1) and four larger mortality-risk based groupings (Table A2) , which we used in analyses requiring larger numbers. The latter grouping was created based on the current literature and clinical judgment about the prognosis of the individual diagnoses.
To categorise individuals into the groups, we used the data on diagnosis and birth characteristics that we had extracted from existing databases and case-notes, and used them to assign for each patient up to five diagnostic codes using the European Society for Paediatric Endocrinology (ESPE) classification of paediatric endocrine diagnoses [12] and the international classification of childhood cancer [13] . In addition, associated pituitary hormonal treatments (thyroid hormones, glucocorticoids, sex steroids or gonadotropins, desmopressin) and karyotype results were compiled. Birth characteristics were classified as small for gestational age (SGA) if birth length or weight were below -2 SD for the gestational age. Each patient was then individually assigned to one of the diagnostic categories (Table A1 ) and risk group categories (Table A2 ) combining all the available information. Diagnostic and risk group categorization was done centrally and blind to the mortality or other study outcomes, based on the information provided by each country.
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